Product Code: GVR-4-68040-127-5
Robot-assisted Endoscope Market Growth & Trends:
The global robot-assisted endoscope market size is expected to reach USD 2.36 billion by 2030, registering a CAGR of 8.2% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Age-related medical disorders requiring endoscopic operations are more prevalent as a result of the world's aging population. Endoscopes with robotic assistance assist in overcoming the difficulties of complex procedures on elderly people. Due to their advantages, such as less trauma, shorter hospital stays, and quicker recovery times, minimally invasive surgical methods have become increasingly popular. Surgeons can carry out intricate treatments with more precision and through smaller incisions with the help of robot-assisted endoscopes.
Factors, such as the demand for minimally invasive surgical (MIS) treatments, new product approvals by regulatory bodies like the U.S. FDA, and the prevalence of chronic illnesses are boosting the market growth. Moreover, the increasing collaboration activities among key players for the development of laparoscopy instruments drive market growth. For instance, in February 2021, Asensus Surgical Inc. and the Amsterdam Skills Centre, Netherlands partnered to create a second European Surgical Training Site for Senhance Digital Laparoscopy. The use of this robotic system in general surgery, including endoscopic operations, is recommended. Thus, it is anticipated that the market in this region will rise at a faster rate during the projected period as a result of the rising prevalence of bowel disorders, the growing elderly population, and the presence of major players with ongoing product advancements.
To prioritize COVID-19 patients and lower the danger of transmission during the pandemic, several healthcare facilities put off elective operations. The lack of urgent endoscopic treatments temporarily decreased the demand for robot-assisted endoscopes. To shorten hospital stays and lower the danger of infection, there was a growing emphasis on adopting minimally invasive surgical methods. As robot-assisted endoscopes provide advantages in terms of smaller incisions and quicker recovery times, this shift in desire may have had a favorable impact on their uptake. The COVID-19 pandemic raised attention to the value of cutting-edge medical technologies and sped up research and development initiatives within the healthcare sector. System improvements for robot-assisted endoscopy may have resulted from this greater emphasis on innovation and technology.
In addition, the market growth is driven by an increase in the number of mergers & acquisitions in the healthcare sector as well as significant investments for its improvement. In May 2022, Creo Medical Group, a significant manufacturer of medical devices, signed a long-term partnership agreement with Intuitive, a leader in robotic surgery and a global pioneer in less-invasive care, to promote compatibility among Creo surgery technology and therapeutic robotic systems. Patients will have more state-of-the-art treatment options due to the combination of Creo's Kamaptive technology and Intuitive's robotic platform. On the other hand, the market growth is likely to be hampered by the high cost of endoscopic treatments and a shortage of qualified personnel. The market will be challenged by a scarcity of qualified workers and a lack of healthcare facilities in developing nations.
Robot-assisted Endoscope Market Report Highlights:
- Based on the end-use, the outpatient facilities segment dominated the market with a market share of 53.31% in 2022
- Robotic systems are employed to perform endoscopic treatments with more accuracy and dexterity, improving patient outcomes and diagnostic precision
- North America dominated the global market with a revenue share of 41.81% of the revenue share in 2022
- Both the United States and Canada have established regulatory frameworks for medical devices, including robot-assisted endoscopes, which have facilitated their entry into the market
- The FDA clearance of the robotic endoscopy devices creates a positive impact on enhancing the product portfolio for the industry's key players
- For instance, in March 2021, the Senhance Surgical System was approved by the FDA in the U.S., according to a statement from Asensus Surgical Inc. It was advised to use this robotic system for endoscopy and other general surgery procedures
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Information Procurement
- 1.2. Information or Data Analysis
- 1.3. Market Scope & Segment Definition
- 1.4. Market Model
- 1.4.1. Market Study, By Company Market Share
- 1.4.2. Regional Analysis
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing incidence of chronic disease
- 3.2.1.2. Technological advancements of robot-assisted endoscopes
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost of endoscopic systems
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. End-use Business Analysis
- 4.1. Robot-Assisted Endoscopes Market: End-use Movement Analysis
- 4.2. Hospitals
- 4.2.1. Hospitals Market, 2018 - 2030 (USD Million)
- 4.3. Outpatient Facilities
- 4.3.1. Outpatient Facilities Market, 2018 - 2030 (USD Million)
Chapter 5. Regional Business Analysis
- 5.1. Robot-Assisted Endoscopes Market Share By Region, 2022 & 2030
- 5.2. North America
- 5.2.1. SWOT Analysis
- 5.2.2. North America Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.2.3. U.S.
- 5.2.3.1. Key Country Dynamics
- 5.2.3.2. Target Disease Prevalence
- 5.2.3.3. Competitive Scenario
- 5.2.3.4. Regulatory Framework
- 5.2.3.5. U.S. Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.2.4. Canada
- 5.2.4.1. Key Country Dynamics
- 5.2.4.2. Target Disease Prevalence
- 5.2.4.3. Competitive Scenario
- 5.2.4.4. Regulatory Framework
- 5.2.4.5. Canada Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.3. Europe
- 5.3.1. SWOT Analysis
- 5.3.2. Europe Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.3.3. UK
- 5.3.3.1. Key Country Dynamics
- 5.3.3.2. Target Disease Prevalence
- 5.3.3.3. Competitive Scenario
- 5.3.3.4. Regulatory Framework
- 5.3.3.5. UK Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.3.4. Germany
- 5.3.4.1. Key Country Dynamics
- 5.3.4.2. Target Disease Prevalence
- 5.3.4.3. Competitive Scenario
- 5.3.4.4. Regulatory Framework
- 5.3.4.5. Germany Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.3.5. France
- 5.3.5.1. Key Country Dynamics
- 5.3.5.2. Target Disease Prevalence
- 5.3.5.3. Competitive Scenario
- 5.3.5.4. Regulatory Framework
- 5.3.5.5. France Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.3.6. Italy
- 5.3.6.1. Key Country Dynamics
- 5.3.6.2. Target Disease Prevalence
- 5.3.6.3. Competitive Scenario
- 5.3.6.4. Regulatory Framework
- 5.3.6.5. Italy Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.3.7. Spain
- 5.3.7.1. Key Country Dynamics
- 5.3.7.2. Target Disease Prevalence
- 5.3.7.3. Competitive Scenario
- 5.3.7.4. Regulatory Framework
- 5.3.7.5. Spain Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.3.8. Denmark
- 5.3.8.1. Key Country Dynamics
- 5.3.8.2. Target Disease Prevalence
- 5.3.8.3. Competitive Scenario
- 5.3.8.4. Regulatory Framework
- 5.3.8.5. Denmark Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.3.9. Sweden
- 5.3.9.1. Key Country Dynamics
- 5.3.9.2. Target Disease Prevalence
- 5.3.9.3. Competitive Scenario
- 5.3.9.4. Regulatory Framework
- 5.3.9.5. Sweden Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.3.10. Norway
- 5.3.10.1. Key Country Dynamics
- 5.3.10.2. Target Disease Prevalence
- 5.3.10.3. Competitive Scenario
- 5.3.10.4. Regulatory Framework
- 5.3.10.5. Norway Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.4. Asia Pacific
- 5.4.1. SWOT Analysis
- 5.4.2. Asia Pacific Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.4.3. Japan
- 5.4.3.1. Key Country Dynamics
- 5.4.3.2. Target Disease Prevalence
- 5.4.3.3. Competitive Scenario
- 5.4.3.4. Regulatory Framework
- 5.4.3.5. Japan Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.4.4. China
- 5.4.4.1. Key Country Dynamics
- 5.4.4.2. Target Disease Prevalence
- 5.4.4.3. Competitive Scenario
- 5.4.4.4. Regulatory Framework
- 5.4.4.5. China Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.4.5. India
- 5.4.5.1. Key Country Dynamics
- 5.4.5.2. Target Disease Prevalence
- 5.4.5.3. Competitive Scenario
- 5.4.5.4. Regulatory Framework
- 5.4.5.5. India Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.4.6. Australia
- 5.4.6.1. Key Country Dynamics
- 5.4.6.2. Target Disease Prevalence
- 5.4.6.3. Competitive Scenario
- 5.4.6.4. Regulatory Framework
- 5.4.6.5. Australia Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.4.7. Thailand
- 5.4.7.1. Key Country Dynamics
- 5.4.7.2. Target Disease Prevalence
- 5.4.7.3. Competitive Scenario
- 5.4.7.4. Regulatory Framework
- 5.4.7.5. Thailand Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.4.8. South Korea
- 5.4.8.1. Key Country Dynamics
- 5.4.8.2. Target Disease Prevalence
- 5.4.8.3. Competitive Scenario
- 5.4.8.4. Regulatory Framework
- 5.4.8.5. South Korea Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.5. Latin America
- 5.5.1. SWOT Analysis
- 5.5.2. Latin America Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.5.3. Brazil
- 5.5.3.1. Key Country Dynamics
- 5.5.3.2. Target Disease Prevalence
- 5.5.3.3. Competitive Scenario
- 5.5.3.4. Regulatory Framework
- 5.5.3.5. Brazil Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.5.4. Mexico
- 5.5.4.1. Key Country Dynamics
- 5.5.4.2. Target Disease Prevalence
- 5.5.4.3. Competitive Scenario
- 5.5.4.4. Regulatory Framework
- 5.5.4.5. Mexico Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.5.5. Argentina
- 5.5.5.1. Key Country Dynamics
- 5.5.5.2. Target Disease Prevalence
- 5.5.5.3. Competitive Scenario
- 5.5.5.4. Regulatory Framework
- 5.5.5.5. Argentina Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.6. MEA
- 5.6.1. SWOT Analysis
- 5.6.2. MEA Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.6.3. South Africa
- 5.6.3.1. Key Country Dynamics
- 5.6.3.2. Target Disease Prevalence
- 5.6.3.3. Competitive Scenario
- 5.6.3.4. Regulatory Framework
- 5.6.3.5. South Africa Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.6.4. Saudi Arabia
- 5.6.4.1. Key Country Dynamics
- 5.6.4.2. Target Disease Prevalence
- 5.6.4.3. Competitive Scenario
- 5.6.4.4. Regulatory Framework
- 5.6.4.5. Saudi Arabia Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.6.5. UAE
- 5.6.5.1. Key Country Dynamics
- 5.6.5.2. Target Disease Prevalence
- 5.6.5.3. Competitive Scenario
- 5.6.5.4. Regulatory Framework
- 5.6.5.5. UAE Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
- 5.6.6. Kuwait
- 5.6.6.1. Key Country Dynamics
- 5.6.6.2. Target Disease Prevalence
- 5.6.6.3. Competitive Scenario
- 5.6.6.4. Regulatory Framework
- 5.6.6.5. Kuwait Robot-Assisted Endoscopes Market, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
- 6.1. Company Categorization
- 6.2. Strategy Mapping
- 6.3. Company Market Position Analysis, 2022
- 6.4. Company Profiles/Listing
- 6.4.1. Asensus Surgical US, Inc.
- 6.4.1.1. Overview
- 6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 6.4.1.3. Product Benchmarking
- 6.4.1.4. Strategic Initiatives
- 6.4.2. Intuitive Surgical
- 6.4.2.1. Overview
- 6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 6.4.2.3. Product Benchmarking
- 6.4.2.4. Strategic Initiatives
- 6.4.3. Auris Health, Inc.
- 6.4.3.1. Overview
- 6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 6.4.3.3. Product Benchmarking
- 6.4.3.4. Strategic Initiatives
- 6.4.4. Johnson & Johnson Services, Inc.
- 6.4.4.1. Overview
- 6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 6.4.4.3. Product Benchmarking
- 6.4.4.4. Strategic Initiatives
- 6.4.5. Brainlab AG
- 6.4.5.1. Overview
- 6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 6.4.5.3. Product Benchmarking
- 6.4.5.4. Strategic Initiatives
- 6.4.6. Medtronic plc.
- 6.4.6.1. Overview
- 6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 6.4.6.3. Product Benchmarking
- 6.4.6.4. Strategic Initiatives
- 6.4.7. Boston Scientific Corporation
- 6.4.7.1. Overview
- 6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 6.4.7.3. Product Benchmarking
- 6.4.7.4. Strategic Initiatives
- 6.4.8. Stryker
- 6.4.8.1. Overview
- 6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 6.4.8.3. Product Benchmarking
- 6.4.8.4. Strategic Initiatives